An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Investigational Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Followers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with numerous of members share comparison images, administration instructions and assertions of rapid British shipping. Vendors market the drug there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Professionals Express Concerns
Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in users injecting products of uncertain source.
Several professionals said the demand for retatrutide could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several content creators try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Platform Response and Material Elimination
According to TikTok, the service has removed violative content and banned associated hashtags and search suggestions. The organization said it was committed to maintaining the platform safe and investing in strengthening compliance measures.
Online Trading Activities
Investigations also discovered groups with up to nine thousand members marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of users, filled with photos of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at residence.
After minutes of entering one group, a seller shared WhatsApp details, where most purchases occur. The vendor provided an guidebook and promised shipping within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, health issues or past usage.
Product Details and Costs
Within these groups, posts show dark colored packages with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually priced at £160 for 20mg. When questioned how long a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram said it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting materials they can’t verify. Although the research behind retatrutide is sound, these online versions may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her team has previously seen patients injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company experimental substance not yet approved … may subject users to possibly significant health risks”.
